Irreversible Loss of Brain Function (ILBF)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Irreversible Loss of Brain Function (ILBF) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Not Yet RecruitingNot Applicable

NCT06293170

Automated Screening for Clinically Ascertained Loss of Cerebral Functions

Rationale: The low organ donation rate in Germany is associated with the inadequate identification of patients at risk of developing irreversible loss of brain…

Germany4,800 participantsStarted 2024-05-01

Treatment: DETECT, Conventional care